A detailed history of Citigroup Inc transactions in Lifevantage Corp stock. As of the latest transaction made, Citigroup Inc holds 2,975 shares of LFVN stock, worth $19,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,975
Previous 3,758 20.84%
Holding current value
$19,664
Previous $49,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$9.73 - $14.51 $7,618 - $11,361
-783 Reduced 20.84%
2,975 $28,000
Q2 2025

Aug 11, 2025

BUY
$11.18 - $16.05 $38,548 - $55,340
3,448 Added 1112.26%
3,758 $49,000
Q1 2025

May 12, 2025

SELL
$14.42 - $25.62 $141,878 - $252,075
-9,839 Reduced 96.95%
310 $4,000
Q4 2024

Feb 12, 2025

BUY
$11.34 - $17.85 $115,089 - $181,159
10,149 New
10,149 $178,000
Q2 2022

Aug 10, 2022

BUY
$3.82 - $4.89 $1,910 - $2,445
500 New
500 $2,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $83M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.